From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Oncology and Hematology>
  4. Editor's Picks

Oncology and Hematology Editor's Picks

Screening for Lung Cancer: Radiography? No. Low-Dose CT? Maybe.

Low-dose computed tomography was a more effective screening tool than chest radiography, but its high sensitivity came with low specificity.

SUMMARY AND COMMENT

No Evidence of Adverse Outcomes from Long-Term Statin Therapy

Vascular benefits persist, without elevated risk for nonvascular morbidity or cancer.

SUMMARY AND COMMENT

Sexual Activity After Menopause

Most WHI participants reported being satisfied with their sexual activity.

SUMMARY AND COMMENT

Do Squamous Cell Carcinomas Develop More Rapidly in Patients Treated with Etanercept?

Watch for nonmelanoma skin cancer in patients with previous UV therapy who are receiving biologic therapy.

SUMMARY AND COMMENT

Prothrombin Complex Concentrate Reverses the Effects of Rivaroxaban but Not Dabigatran

In healthy volunteers, coagulation test results rapidly normalized with a PCC after factor Xa — but not direct thrombin — inhibition.

SUMMARY AND COMMENT

Aspirin 600 mg Daily Reduced Cancers in Lynch Syndrome

Patients randomized to aspirin for 2 years had about half the risk for colorectal cancer as a placebo group.

Preoperative Anemia Is a Prognostic Factor for Poor Outcomes After Noncardiac Surgery

Even mild anemia is associated with higher perioperative morbidity and mortality, but should we change our practice?

SUMMARY AND COMMENT

Detection Rates Are Similar for Digital and Film MammographyFree

Digital mammography had better sensitivity when breast tissue was dense.

SUMMARY AND COMMENT

Solid Organ Transplant Recipients Have Doubled Risk for Cancer

Lymphoma and lung cancer were most common.

SUMMARY AND COMMENT

Clopidogrel Dosing Based on Genotype: What Difference Does It Make?

In patients heterozygous for the CYP2C19*2 allele, higher doses significantly reduced platelet reactivity, but whether genotype-guided dosing improves outcomes remains unknown.

Read more Oncology and Hematology Editor's Picks articles >>

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

Browse arrow

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Copyright © 2012. Massachusetts Medical Society. All rights reserved.